Schonfeld Strategic Advisors LLC - 31 Mar 2025 SCHEDULE 13G Report for Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share (MRSN)

Filing Manager: Schonfeld Strategic Advisors LLC
Reporting Manager: Schonfeld Strategic Advisors LLC
Security: Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: MRSN
Shares outstanding: 125M shares
Disclosed Ownership: 7.61M shares
Ownership: 6.11%
Form type: SCHEDULE 13G
Filing time: 15 May 2025, 16:31:50 UTC
Date of event: 31 Mar 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Schonfeld Strategic Advisors LLC	6.11%	7.61M	7.61M	0	/s/ Hung Luc	Hung Luc, Chief Compliance Officer